Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Gintsburg

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Acta Naturae|April 27, 2019
Immunogenicity of Different Forms of Middle East Respiratory Syndrome S GlycoproteinT A Ozharovskaia, O V Zubkova, I V Dolzhikova, et al.
Acta Naturae|April 23, 2025
The Parameters of Long-Term Humoral Immunity Induced by a Single Injection of the Sputnik Light Vaccine Among Noninfected Volunteers and Those Infected with SARS-CoV-2F M Izhaeva, A I Tukhvatulin, A S Dzharullaeva, et al.
Bulletin of Experimental Biology and Medicine|November 28, 2017
Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) with Additional Protein Domain Synthesized in E. coli: In Vivo Osteoinductivity in Experimental Models on Small and Large Laboratory AnimalsM S Bartov, A V Gromov, V N Manskih, et al.
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|June 19, 2012
[Production of mycobacterial antigenes merged with cellulose binding protein domain in order to produce subunit vaccines against tuberculosis]O V Sergienko, A M Liashchuk, E I Aksenova, et al.
Acta Naturae|February 7, 2022
Nanobodies Are Potential Therapeutic Agents for the Ebola Virus InfectionI B Esmagambetov, D V Shcheblyakov, D A Egorova, et al.
Acta Virologica|November 5, 2020
Variability of nonpathogenic influenza virus H5N3 under immune pressureT A Timofeeva, I A Rudneva, G K Sadykova, et al.
Voprosy Virusologii|June 2, 2023
[Evaluation of the dynamics of detection of viable SARS-CoV-2 (Coronaviridae: <i>Betacoronavirus: Sarbecovirus</i>) in biological samples obtained from patients with COVID-19 in a health care setting, as one of the indicators of the infectivity of the virus]N A Kuznetsova, D A Ogarkova, V A Gushchin, et al.
Voprosy Virusologii|May 26, 2026
[Comparison of candidate vaccines against Tick-borne encephalitis based on mRNA, simian adenovirus serotype 25 and a chimeric replication-competent yellow fever vaccine strain]A E Siniavin, V A Gushchin, N A Kuznetsova, et al.
Acta Naturae|November 11, 2020
Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory SyndromeI V Dolzhikova, D M Grousova, O V Zubkova, et al.
Acta Naturae|January 18, 2024
In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2A N Narovlyansky, M V Filimonova, N G Tsyshkova, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Acta Naturae|April 27, 2019
Immunogenicity of Different Forms of Middle East Respiratory Syndrome S GlycoproteinT A Ozharovskaia, O V Zubkova, I V Dolzhikova, et al.
Acta Naturae|April 23, 2025
The Parameters of Long-Term Humoral Immunity Induced by a Single Injection of the Sputnik Light Vaccine Among Noninfected Volunteers and Those Infected with SARS-CoV-2F M Izhaeva, A I Tukhvatulin, A S Dzharullaeva, et al.
Bulletin of Experimental Biology and Medicine|November 28, 2017
Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) with Additional Protein Domain Synthesized in E. coli: In Vivo Osteoinductivity in Experimental Models on Small and Large Laboratory AnimalsM S Bartov, A V Gromov, V N Manskih, et al.
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|June 19, 2012
[Production of mycobacterial antigenes merged with cellulose binding protein domain in order to produce subunit vaccines against tuberculosis]O V Sergienko, A M Liashchuk, E I Aksenova, et al.
Acta Naturae|February 7, 2022
Nanobodies Are Potential Therapeutic Agents for the Ebola Virus InfectionI B Esmagambetov, D V Shcheblyakov, D A Egorova, et al.
Acta Virologica|November 5, 2020
Variability of nonpathogenic influenza virus H5N3 under immune pressureT A Timofeeva, I A Rudneva, G K Sadykova, et al.
Voprosy Virusologii|June 2, 2023
[Evaluation of the dynamics of detection of viable SARS-CoV-2 (Coronaviridae: <i>Betacoronavirus: Sarbecovirus</i>) in biological samples obtained from patients with COVID-19 in a health care setting, as one of the indicators of the infectivity of the virus]N A Kuznetsova, D A Ogarkova, V A Gushchin, et al.
Voprosy Virusologii|May 26, 2026
[Comparison of candidate vaccines against Tick-borne encephalitis based on mRNA, simian adenovirus serotype 25 and a chimeric replication-competent yellow fever vaccine strain]A E Siniavin, V A Gushchin, N A Kuznetsova, et al.
Acta Naturae|November 11, 2020
Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory SyndromeI V Dolzhikova, D M Grousova, O V Zubkova, et al.
Acta Naturae|January 18, 2024
In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2A N Narovlyansky, M V Filimonova, N G Tsyshkova, et al.
Pageof 20